首页> 外文期刊>Clinical Psychopharmacology and Neuroscience >Advanced Test of Attention in Children with Attention-Deficit/Hyperactivity Disorder in Japan for Evaluation of Methylphenidate and Atomoxetine Effects
【24h】

Advanced Test of Attention in Children with Attention-Deficit/Hyperactivity Disorder in Japan for Evaluation of Methylphenidate and Atomoxetine Effects

机译:日本注意力缺陷/多动障碍儿童注意力的高级测试,用于评估哌醋甲酯和阿莫西汀的作用

获取原文
           

摘要

Objective This study was conducted to validate the Advanced Test of Attention (ATA) of the visual attention version of Japanese children with attention deficit/hyperactivity disorder (ADHD) and to evaluate the efficacy of methylphenidate (OROS-MPH) and atomoxetine medications. Methods To assess pharmacotherapy efficacy, the visual version of ATA was administered to 42 children with ADHD. Results were assessed using discriminant analysis, ANOVA for indices of ATA before and after medication treatment, and correlation analysis between the improvement of indices of ATA and clinical symptoms during medication treatment. Results Discriminant analysis showed that 69.0% of ADHD children were assigned correctly. The T score of commission errors increased as the trial progressed on the medication-off condition. T scores of commission errors and standard deviation of response times on medication-on condition were low compared to the medication-off condition. A few significant correlations were found between the improvements of indices of ATA and ADHD-Rating Scale (RS) during treatment. Conclusion The performance of the visual version of ATA on medication-off condition reflected the features of ADHD. Furthermore, the medication treatment effects were confirmed sufficiently. In addition, results suggest that indices of ATA reflected aspects of ADHD symptoms that are difficult to elucidate for ADHD-RS. For assessing symptoms and effects of medical treatment in children with ADHD, ATA might be a useful assessment tool.
机译:目的进行本研究以验证日本患有注意力缺陷/多动障碍(ADHD)的儿童的视觉注意版本的高级注意测试(ATA),并评估哌醋甲酯(OROS-MPH)和阿托西汀药物的疗效。方法为评估药物治疗的有效性,对42例多动症儿童进行了视觉检查。使用判别分析,ANOVA药物治疗前后的ATA指数以及药物治疗过程中ATA指数的改善与临床症状之间的相关性分析评估结果。结果判别分析表明,正确分配多动症儿童的比例为69.0%。随着试验在停药状态下进行,佣金错误的T分数增加。与停药状态相比,在停药状态下的佣金误差T分数和响应时间的标准偏差低。治疗期间ATA指数和ADHD评分量表(RS)的改善之间发现了一些显着的相关性。结论ATA视觉版本在停药状态下的性能反映了ADHD的特征。此外,充分确认了药物治疗效果。此外,结果表明,ATA指数反映了ADHD症状的方面,而ADHD-RS难以阐明。为了评估多动症儿童的症状和药物治疗效果,ATA可能是有用的评估工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号